TP53 and neoplasm: NKD2 methylation was significantly associated with tumor stage (p < 0.05), but no association was found between NKD2 methylation and age, tumor grade, tumor size, Lymph node metastasis, and the expression of ER, PR, HER2, p53 or Ki-67 (all p > 0.05).